Agenda: digbiomarkerseu.com/agenda

2:25 pm GMT
Why is Real World Walking Speed so important as a Digital Biomarker in Movement-related Disorders?
- The experience with outcome measures in MS trials
- Dialogue with EMA & FDA about regulatory acceptance, including MDR/GDPR
- The future: Cloud computing, multi-sensor tools and understandable AI

Martin Daumer, Scientific Director | Honorary Professor, Sylvia Lawry Centre for Multiple Sclerosis | Technical University of Munich